Intracranial Atherosclerotic Disease Treatment Market

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.
Intracranial Atherosclerotic Disease Treatment Market contains market size and forecasts of Intracranial Atherosclerotic Disease Treatment in global, including the following market information:
Global Intracranial Atherosclerotic Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Intracranial Atherosclerotic Disease Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Intracranial Atherosclerotic Disease Treatment companies in 2021 (%)
The global Intracranial Atherosclerotic Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Intracranial Atherosclerotic Disease Treatment include Stryker, Balt, TERUMO, MicroPort and Acandis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intracranial Atherosclerotic Disease Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intracranial Atherosclerotic Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intracranial Atherosclerotic Disease Treatment Market Segment Percentages, by Type, 2021 (%)
Stent
PTA Balloon
Global Intracranial Atherosclerotic Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intracranial Atherosclerotic Disease Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global Intracranial Atherosclerotic Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intracranial Atherosclerotic Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intracranial Atherosclerotic Disease Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Intracranial Atherosclerotic Disease Treatment revenues share in global market, 2021 (%)
Key companies Intracranial Atherosclerotic Disease Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Intracranial Atherosclerotic Disease Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Stryker
Balt
TERUMO
MicroPort
Acandis